Events and Presentations
Digestive Disease Week (DDW) 2024
Franziska Buriánek, M.D., Senior Medical Director at Immunic, will present data from Immunic’s phase 1b clinical trial of IMU-856, an orally available and systemically acting small molecule modulator that targets SIRT6 (Sirtuin 6), in patients with celiac disease, in an oral presentation.
- Presentation Title: First In Human Trial Of IMU-856, An Orally Available Epigenetic Modulator Of Barrier Regeneration For The Treatment Of Celiac Disease
- Abstract ID: 4025905
- Session Title: Since Sliced Bread: Best in Celiac 2024
- Session Type: Research Forum
- Session Date: Monday, May 20, 2024
- Session Time: 2:00 - 3:30 pm EDT